Oral Oncology
Volume 46, Issue 8 , Pages 577-585 , August 2010

Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck

  • Johannes A. Langendijk

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen/University of Groningen, Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, University Medical Center Groningen, P.O. Box 30001, 9300 RB Groningen, The Netherlands. Tel.: +31 50 3611190; fax: +31 50 3611692.
    • ,
  • Alfio Ferlito

      Affiliations

    • Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
    • ,
  • Robert P. Takes

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    • ,
  • Juan P. Rodrigo

      Affiliations

    • Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
    • ,
  • Carl Suárez

      Affiliations

    • Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
    • ,
  • Primo Strojan

      Affiliations

    • Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
    • ,
  • Missak Haigentz Jr.

      Affiliations

    • Department of Medicine, Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
    • ,
  • Alessandra Rinaldo

      Affiliations

    • Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy

Received 24 February 2010 ,Revised 29 March 2010 ,Accepted 29 March 2010.

References 

  1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695–1709
  2. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368:843–854
  3. Pignon JP, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol. 2009;92:4–14
  4. Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol, 2009.
  5. Genden EM, Ferlito A, Silver CE, Takes RP, Suárez C, Owen RP, et al. Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol. 2010;
  6. Haigentz Jr M, Silver CE, Corry J, Genden EM, Takes RP, Rinaldo A, et al. Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol, 2009.
  7. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009;266:1333–1352
  8. Mendenhall WM, Hinerman RW, Amdur RJ, Malyapa RS, Lansford CD, Werning JW, et al. Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Clin Med Res. 2006;4:200–208
  9. Rodrigo JP, Maseda E, Maldonado M, Aldama P, Puente M, Llorente JL, et al. Efficacy of postoperative radiation therapy for squamous cell carcinoma of the head and neck: results of a prospective randomised clinical trial. Acta Otorrinolaringol Esp. 2004;55:415–419
  10. Martin H. The treatment of cervical metastatic cancer. Ann Surg. 1941;114:972–985
  11. Strong MS, Vaughan CW, Kayne HL, Aral IM, Ucmakli A, Feldman M, et al. A randomized trial of preoperative radiotherapy in cancer of the oropharynx and hypopharynx. Am J Surg. 1978;136:494–500
  12. Mantravadi RV, Skolnik EM, Applebaum EL. Complications of postoperative and preoperative radiation therapy in head and neck cancers. A comparative study. Arch Otolaryngol. 1981;107:690–693
  13. Tupchong L, Scott CB, Blitzer PH, Marcial VA, Lowry LD, Jacobs JR, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73–03. Int J Radiat Oncol Biol Phys. 1991;20:21–28
  14. Vandenbrouck C, Sancho H, Le Fur R, Richard JM, Cachin Y. Results of a randomized clinical trial of preoperative irradiation versus postoperative in treatment of tumors of the hypopharynx. Cancer. 1977;39:1445–1449
  15. Wennerberg J. Pre versus post-operative radiotherapy of resectable squamous cell carcinoma of the head and neck. Acta Otolaryngol. 1995;115:465–474
  16. Chen TC, Wang CT, Ko JY, Lou PJ, Yang TL, Ting LL, et al. Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck. Head Neck, 2009.
  17. Byers RM, Clayman GL, McGill D, Andrews T, Kare RP, Roberts DB, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck. 1999;21:499–505
  18. Bartelink H, Breur K, Hart G, Annyas B, van Slooten E, Snow G. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer. 1983;52:1008–1013
  19. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg. 1993;166:360–365
  20. Frank JL, Garb JL, Kay S, McClish DK, Bethke KP, Lind DS, et al. Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg. 1994;168:476–480
  21. Huang D, Johnson CR, Schmidt-Ullrich RK, Sismanis A, Neifeld JP, Weber J. Incompletely resected advanced squamous cell carcinoma of the head and neck: the effectiveness of adjuvant vs. salvage radiotherapy. Radiother Oncol. 1992;24:87–93
  22. Huang DT, Johnson CR, Schmidt-Ullrich R, Grimes M. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys. 1992;23:737–742
  23. Hicks WL, Loree TR, Garcia RI, Maamoun S, Marshall D, Orner JB, et al. Squamous cell carcinoma of the floor of mouth: a 20-year review. Head Neck. 1997;19:400–405
  24. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Does adjuvant radiation therapy improve outcomes in pT1–3N0 oral cavity cancer with tumor-free margins and perineural invasion?. Int J Radiat Oncol Biol Phys. 2008;71:371–376
  25. Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 1998;40:529–534
  26. Nisi KW, Foote RL, Bonner JA, McCaffrey TV. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys. 1998;41:371–377
  27. Suarez C, Llorente JL, Nunez F, Diaz C, Gomez J. Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas. Otolaryngol Head Neck Surg. 1993;109:3–9
  28. Suarez C, Rodrigo JP, Herranz J, Llorente JL, Martinez JA. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol. 1995;104:358–363
  29. Mendenhall WM, Amdur RJ, Hinerman RW, Villaret DB, Siemann DW. Postoperative radiation therapy for squamous cell carcinoma of the head and neck. Am J Otolaryngol. 2003;24:41–50
  30. Moergel M, Jahn-Eimermacher A, Krummenauer F, Reichert TE, Wagner W, Wendt TG, et al. Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state) – a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design. Trials. 2009;10:118
  31. Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26:3–11
  32. Langendijk JA, de Jong MA, Leemans CR, De Bree R, Smeele LE, Doornaert P, et al. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time. Int J Radiat Oncol Biol Phys. 2003;57:693–700
  33. Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys. 1989;16:25–36
  34. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer. 2005;104:1408–1417
  35. Jonkman A, Kaanders JH, Terhaard CH, Hoebers FJ, Van den Ende PL, Wijers OB, et al. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:119–125
  36. Leon X, Lopez M, Pineiro Z, Langendijk JA, Leemans CR, Quer M. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck. 2007;29:815–821
  37. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21:555–563
  38. Schiff PB, Harrison LB, Strong EW, Fass DE, Shah JP, Spiro R, et al. Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol. 1990;43:203–208
  39. Vikram B, Strong EW, Shah J, Spiro RH. Elective postoperative radiation therapy in stages III and IV epidermoid carcinoma of the head and neck. Am J Surg. 1980;140:580–584
  40. Kajanti M, Holsti LR, Holsti P. Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrence. Radiother Oncol. 1991;22:174–179
  41. Trotti A, Klotch D, Endicott J, Ridley M, Greenberg H. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1993;26:13–21
  42. Ampil FL, Buechter KJ, Bairnsfather LE, Shockley WW. Timing and dosage of postoperative radiotherapy for squamous cell carcinoma of the upper aerodigestive tract. J Oral Maxillofac Surg. 1993;51:1194–1197
  43. Dixit S, Vyas RK, Toparani RB, Baboo HA, Patel DD. Surgery versus surgery and postoperative radiotherapy in squamous cell carcinoma of the buccal mucosa: a comparative study. Ann Surg Oncol. 1998;5:502–510
  44. Bastit L, Blot E, Debourdeau P, Menard J, Bastit P, Le Fur R. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2001;49:139–146
  45. Withers HR, Maciejewski B, Taylor JM, Hliniak A. Accelerated repopulation in head and neck cancer. Front Radiat Ther Oncol. 1988;22:105–110
  46. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131–146
  47. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–578
  48. Awwad HK, Lotayef M, Shouman T, Begg AC, Wilson G, Bentzen SM, et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Br J Cancer. 2002;86:517–523
  49. Suwinski R, Bankowska-Wozniak M, Majewski W, Idasiak A, Maciejewski A, Ziolkowska E, et al. Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer. Radiother Oncol. 2008;87:155–163
  50. Sanguineti G, Sormani MP, Benasso M, Corvo R, Foppiano F, Ricci I, et al. Late local treatment morbidity after accelerated radiotherapy or alternating chemoradiotherapy for advanced head and neck carcinoma. Tumori. 2002;88:313–320
  51. Sanguineti G, Richetti A, Bignardi M, Corvo’ R, Gabriele P, Sormani MP, et al. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study. Int J Radiat Oncol Biol Phys. 2005;61:762–771
  52. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer – the time factor. Int J Radiat Oncol Biol Phys. 1997;39:831–836
  53. Smeele LE, Leemans CR, Langendijk JA, Tiwari R, Slotman BJ, Der Waal I, et al. Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy. Head Neck. 2000;22:559–563
  54. Pfreundner L, Willner J, Marx A, Hoppe F, Beckmann G, Flentje M. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys. 2000;47:1287–1297
  55. Zelefsky MJ, Harrison LB, Armstrong JG. Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer. 1992;70:2388–2395
  56. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med. 2004;350:1945–1952
  57. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Engl J Med. 2004;350:1937–1944
  58. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999–1004
  59. Smid L, Budihna M, Zakotnik B, Soba E, Strojan P, Fajdiga I, et al. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:1055–1062
  60. Zakotnik B, Budihna M, Smid L, Soba E, Strojan P, Fajdiga I, et al. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with mitomycin C and bleomycin. Int J Radiat Oncol Biol Phys. 2007;67:685–690
  61. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–850
  62. Pignon JP, le Maitre A, Bourhis J. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys. 2007;69:S112–S114
  63. McLaughlin MP, Parsons JT, Fein DA, Stringer SP, Cassisi NJ, Mendenhall WM, et al. Salvage surgery after radiotherapy failure in T1–T2 squamous cell carcinoma of the glottic larynx. Head Neck. 1996;18:229–235
  64. Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle JO, et al. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg. 2006;132:59–66
  65. Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck. 2006;28:107–113
  66. Kasperts N, Slotman BJ, Leemans CR, De Bree R, Doornaert P, Langendijk JA. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer. 2006;106:1536–1547
  67. Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008;26:5518–5523
  68. Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009;73:399–409

☆ This paper was written by members and invitees of the International Head and Neck Scientific Group (www.IHNSG.com).

PII: S1368-8375(10)00135-1

doi: 10.1016/j.oraloncology.2010.03.023

Oral Oncology
Volume 46, Issue 8 , Pages 577-585 , August 2010

Article Tools